TG Therapeutics Inc. (NASDAQ: TGTX) announced it has completed enrollment in the randomized portion of its Phase 3 ENHANCE trial ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE